There's a dearth of genetic counselors in the US, NPR's Morning Edition reports.
With less commotion, gene-editing experiments involving human embryos continue on, Nature News writes.
In PNAS this week: antibiotic affects E. coli mutation rate, nanopore sequencing development, and more.
Genes associated with risk taking can account for some of the variation in the age at which someone loses his or her virginity, a study suggests.
Liquid biopsies offer a non-invasive way of detecting and monitoring cancer, though the techniques still need polishing, Nature News reports.
Dashed hopes among investors regarding Theranos may spill over to affect other growing diagnostic companies, Steve Brozak, the president of WBB Securities, writes at Stat News.
In the PLOS journals this week: antimicrobial resistance patterns in Klebsiella pneumoniae, and more.
A CRIPSR-Cas9-edited mushroom falls outside US Department of Agriculture regulations, Nature News reports.
The Netherlands is pushing the European Union to make a move on open access.
A company's DNA-guided training program can improve performance, according to a study.
In Science this week: parasites with resistance to antimalarial drug can't pass it on, and more.
Regulators have proposed banning Theranos CEO from owning or operating any lab for two years, the Wall Street Journal reports.
President Barack Obama hosted his final White House science fair that highlighted innovative work by students in STEM fields.
BGI is seeking an IPO on a Shenzhen-based stock exchange, but the timing of when this might occur is unclear, FinanceAsia reports.
In Nature this week: researchers uncover 13 healthy people who harbor Mendelian disease mutations, new tree of life, and more.
The editorial board of the New York Times calls for better support for analyses of already-collected clinical trial data.
Clinical sequencing is no longer the novelty it once was, the Milwaukee Journal-Sentinel reports, though it doesn't always provide the wanted answers.
US regulators are to discuss how to oversee crops modified using new gene-editing techniques.
In Nucleic Acids Research this week: variant caller for DNA and RNA sequences, epigenetic patterns during cotton fiber development, and more.
A University of California, Berkeley-led team has drawn a new tree of life that's heavy on bacteria.
Regulatory agencies and research groups are trying to make it easier to recruit patients into clinical trials, the Wall Street Journal reports.
An Israeli team has developed a longer-lasting banana by tweaking one of its genes, Reuters reports.
In PNAS this week: transfer RNA-derived small RNAs changes in CLL and lung cancer, database that corrects for batch effects, and more.
Researchers from Guangzhou Medical University report on an attempt to modify human embryos using the CRISPR/Cas9 approach so that they are HIV-resistant.
The Senate is assembling its version of the 21st Century Cures Act, but is getting stuck on funding, ScienceInsider says.
Regeneron Pharmaceuticals comes out on top of Science Careers' ranking of best biotech and pharma employers.
A researcher recounts in Science how she got her career off the ground.
Bitesize Bio offers some word of wisdom for designing a new lab.
A study finds that some women choose science majors later in their college careers.